Intrathecal nivolumab and IL-2 for treatment of leptomeningeal metastases in EGFR-mutated lung adenocarcinoma. Ruan Z, Zeng L, Zhang J, Qin H, et al. Lung Cancer 2025;204:108586.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ruan Z, Zeng L, Zhang J, Qin H, et al. Intrathecal nivolumab and IL-2 for treatment of leptomeningeal metastases in EGFR-mutated lung adenocarcinoma. Lung Cancer 2025;204:108586.
PMID: 40412102